*+-HAND diagnostic issues Dr. Robbins of Columbia University shared his perspective on HIV associated neurocognitive disorder (HAND) diagnostic issues as a clinical psychologist and clinical neuropsychologist, and discussed research on HAND screening tools. Typically, providers see patients with concerns about memory problems, slower thinking, or difficulty multi-tasking. In the current era these symptoms are often […]
HAND Diagnostic Issues Read More »
*+-Ten years ago, few people over 50 were being treated for HIV; today they make up one third of the HIV- positive population. Dr. Alan Winston, with the Department of Medicine at Imperial College of London, noted that this is due both to more effective therapy and to more people being infected after age 50. Dr.
Aging, comorbidities, and the brain Read More »
*+-Integrated care for people living with HIV Dr. Claire Kendall, of the University of Ottawa, talked about the opportunities for improving HIV care in Ontario and particularly about the potential for a more integrated model of community care. We know that once people living with HIV are engaged in care they do pretty well. However,
How can we win the Endgame? Read More »
*+-The Canadian HIV Cure Enterprise (canCURE) Dr. Eric Cohen is one of the principal investigators of CanCURE, the Canadian HIV Cure Enterprise. CanCURE began in 2013. It aims to understand the persistence of HIV during antiretroviral therapy (ARV) and to use this knowledge to develop cure interventions. It is a large collaborative group of 28
How close are we to a cure? Read More »
*+-The aging HIV patient and geriatric syndromes: “Will you still treat me when I’m 64?” People living with HIV are getting older due both to extended survival and to an increase in new diagnoses over the age of 50. Dr. Julian Falutz, a geriatrician from the McGill University Health Centre, discussed the impact of geriatric
*+-Aging, comorbidities, and HIV Ten years ago, few people over 50 were being treated for HIV; today this group makes up about one third of the HIV-positive population. This is due to more effective therapy, and also to more people being infected after age 50. Dr. Alan Winston, with the Department of Medicine at Imperial College
Preventing, Predicting and Managing Co-morbidities Read More »
*+-Understanding HIV through art – Andrew Zealley Andrew Zealley, a doctoral student at York University, is an artist living with HIV who has been making art about AIDS since 1988. He talked about two of his bodies of work: Disco Hospital and This is Not Art Therapy. This is Not Art Therapy is also the
Understanding HIV through art Read More »
*+-What’s in the biomedical prevention pipeline? Dan McGowan from the University of Pittsburgh presented emerging possibilities for HIV prevention. Sexual health education, condoms, and male circumcision (which reduces a man’s risk of acquiring HIV by 50% with one procedure) have an established role in HIV prevention. To this we have added oral pre-exposure prophylaxis (PrEP)
The biomedical prevention pipeline Read More »
*+-HIV and mental health in Ontario Dr. Evan Collins, a staff psychiatrist at the Immunodeficiency Clinic of the University Health Network, provided an overview of Ontario research about the mental health of people living with HIV. Mental health conditions are the most common comorbid conditions affecting people living with HIV. An OHIP database study (Kendall
Managing Patients with complex social, mental health and addiction issues Read More »
*+-Conference Introduction: How close are we to the 90-90-90 targets? Dr. Sean Rourke, Scientific and Executive Director of the OHTN, opened the conference by noting that medical discoveries in HIV have extended the lives of many people. To further improve treatment and care for all people living with HIV, the challenge now is to improve
HIV Endgame: Closing the Gaps in the Care Cascade – Introduction Read More »
